Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Galera Therapeutics key operating metrics including Diseases Treated , environmental, and social and governance score (ESG).

Diseases Treated

4

Oct, 2019

Patents (Europe)

7

Oct, 2019

Phase I Trials Products

1

Oct, 2019

Operating Metrics

MetricsOct, 2019
Diseases Treated 4
Patents (Europe)7
Phase I Trials Products1
Facilities Leased (US), square feet14.4K
Drugs in Development2
Phase III Trials Products1
Patents (US)15
Patents Pending (US)6
Patents (Foreign)69
Patents Pending (Foreign)63

Environmental, Social and Governance (ESG)

Overall

40-49 out of 100

Community

Employees

Environment

Governance

Premium Content only available in Craft’s Intelligence Portal
Learn more

Source:CSRHub

Footer menu